NVDA

175.15

-1.66%↓

AAPL

252.73

+0.05%↑

MSFT

373.94

-3.2%↓

TSM

341.86

-0.21%↓

AVGO.US

318.05

-2.23%↓

NVDA

175.15

-1.66%↓

AAPL

252.73

+0.05%↑

MSFT

373.94

-3.2%↓

TSM

341.86

-0.21%↓

AVGO.US

318.05

-2.23%↓

NVDA

175.15

-1.66%↓

AAPL

252.73

+0.05%↑

MSFT

373.94

-3.2%↓

TSM

341.86

-0.21%↓

AVGO.US

318.05

-2.23%↓

NVDA

175.15

-1.66%↓

AAPL

252.73

+0.05%↑

MSFT

373.94

-3.2%↓

TSM

341.86

-0.21%↓

AVGO.US

318.05

-2.23%↓

NVDA

175.15

-1.66%↓

AAPL

252.73

+0.05%↑

MSFT

373.94

-3.2%↓

TSM

341.86

-0.21%↓

AVGO.US

318.05

-2.23%↓

Strona główna・Stock List・Teradata Corp

Teradata Corp

Open

SectorTechnology

26.34 -2.95

Buy Sell

Overview

Share price change

24h

Current

Min

25.72

Max

27.06

Key metrics
By Trading Economics
Income	90M 130M
Sales	5M 421M
P/E Sector Avg	19.756 77.27
EPS	0.74
Profit margin	30.879
Employees	5,100
EBITDA	-9M 76M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+37.71% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	-188M 2.5B
Previous open	29.29
Previous close	26.34

News Sentiment

By Acuity

34%

66%

96 / 376 Ranking in Technology

Technical Score

By Trading Central

Confidence

Neutral Evidence

21.51 / 22.78 Support & Resistance

Teradata Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Market Talk

Major News Events

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Market Talk

Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk

Earnings

Major News Events

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Teradata Corp Forecast

Price Target

By TipRanks

37.71% upside

12 Months Forecast

Average 37.1 USD 37.71%

High 49 USD

Low 30 USD

Based on 10 Wall Street analysts offering 12 month price targets forTeradata Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to Teradata Corp - Dist in the past 3 months.

Technical Score

By Trading Central

21.51 / 22.78Support & Resistance

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

96 / 376 Ranking in Technology

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Teradata Corp

Teradata Corporation, together with its subsidiaries, provides a connected multi-cloud data platform for enterprise analytics. The company offers Teradata Vantage, an open and connected platform designed to leverage data across an enterprise. Its business consulting services include support services for organizations to establish a data and analytic vision, enable a multi-cloud ecosystem architecture, and identify and operationalize analytical opportunities, as well as to ensure the analytical infrastructure delivers value. The company offers support and maintenance services. It serves clients in financial services, government, healthcare and life sciences, manufacturing, retail, telecommunications, and travel/transportation sectors through a direct sales force in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. Teradata Corporation was incorporated in 1979 and is headquartered in San Diego, California.